The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population
- 206 Downloads
Coronary artery disease (CAD) affects Indians 5–6 years earlier than in the west, is diffuse and malignant, and poses a heavy burden on India’s developing economy. Traditional risk factors have failed to explain this high incidence of premature CAD and hence this study investigated the association of two novel risk biomarkers, cystatin C and small dense LDL (sdLDL) with the presence and severity of CAD. Cystatin C and sdLDL were estimated in 204 CAD patients ≤45 years of age and compared with 161 age-matched healthy controls. The traditional lipid profile parameters, i.e., cholesterol, LDL, HDL, triglycerides, apolipoproteins A1 and B, and Lp(a) were also measured in both groups. Cystatin C was significantly raised and mean LDL particle size significantly reduced in CAD patients as compared to controls. 62.7 % of CAD patients showed pattern B while 37.3 % patients showed pattern A. Of the traditional lipid tests, only HDL and apolipoprotein A1 showed a significant decrease in the CAD group. sdLDL was significantly associated with the severity of CAD, while cystatin C was not. Both cystatin C and sdLDL emerged as independent risk factors, however, of the two, sdLDL was a more sensitive predictor of CAD events. Cystatin C and mean LDL particle size are significantly and independently associated with the presence of CAD events in patients ≤45 years with normal kidney function. Hence, these novel risk biomarkers can be useful tools in reducing the morbidity and mortality associated with CAD in the productive Indian workforce.
KeywordsCystatin C Small dense LDL Early detection Coronary artery disease Risk factors
This study was supported by a research grant from the Indian Council of Medical Research (ICMR), New Delhi, India. We also acknowledge, with thanks, the help provided in the statistical analysis by Ms. Parul Takkar Chugh, Statistician, Sir Ganga Ram Hospital, New Delhi, India.
- 3.Enas EA (1998) High rates of coronary artery disease in Asian Indians in the United States despite intensive modification of life style. What next. Curr Sci 74:1081–1086Google Scholar
- 10.Sarnak MJ, Levey AS, Schoolwerth A, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Circulation 108:2154–2169PubMedCrossRefGoogle Scholar
- 19.Shlipak MG, Katz R, Sarnak KJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145:237–246PubMedCrossRefGoogle Scholar
- 30.Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F (2006) Chronic Kidney Disease Epidemiology Collaboration using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145(4):247–254PubMedCrossRefGoogle Scholar
- 36.Taglieri N, Fernandez-Berges DJ, Koenig W, Fernandez JMC, Consuegra-Sanchez L, Robles NR, Sanchez PL et al (2010) Plasma cystatin C for prediction of 1-year cardiac events in mediterranean patients with non-ST elevation acute coronary syndrome. Atherosclerosis 209(1):300–305PubMedCrossRefGoogle Scholar
- 37.Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ (2004) Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15:1307–1315PubMedCrossRefGoogle Scholar
- 44.St-Pierre AC, Cantin B, Dabenais GR, Mauriege P, Benard PM, Despres JP, Lamarche B (2005) Low-density lipoprotein subfractions and the risk of ischemic heart disease in men: 13 year follow up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25:553–559PubMedCrossRefGoogle Scholar
- 46.Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepard J (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106:241–253PubMedCrossRefGoogle Scholar
- 47.Niccoli G, Conte M, Della Bona R, Altamura L, Siviglia M, Dato I, Ferrante G, Lenone AM, Porto I, Burzotta F, Brugaletta S, Biasucci LM, Crea F (2008) Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate. Atherosclerosis 197:853–859CrossRefGoogle Scholar
- 52.Ramachandaran A, Snehlata C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD, Diabetes Epidemiology Study Group in India (DESI) (2001) High levels of diabetes and impaired glucose tolerance in India. National Urban Diabetes Survey. Diabetologia 44:1094–1101CrossRefGoogle Scholar